PT - JOURNAL ARTICLE AU - Rizzo, Toni ED - Chatzidionysiou, Katerina TI - Efficacy of Different Doses of Rituximab for the Treatment of RA: Data from the CERERRA Collaboration DP - 2012 Sep 01 TA - MD Conference Express PG - 11--12 VI - 12 IP - 9 4099 - http://mdc.sagepub.com/content/12/9/11.short 4100 - http://mdc.sagepub.com/content/12/9/11.full AB - The approved dose of rituximab for the treatment of rheumatoid arthritis (RA) is 1000 mg × 2, but some data have suggested similar clinical efficacy with rituximab 500 mg × 2. The objective of this analysis was to compare the efficacy of the 2 doses, given as first or second treatment courses. The data for this analysis were obtained from the European Collaborative Registries for the Evaluation of Rituximab in Rheumatoid Arthritis [CERERRA], which includes 10 European registries.